國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Chemotherapy and immunotherapy in ur...

Lallas, Costas D.

Chemotherapy and immunotherapy in urologic oncologya guide for the advanced practice provider /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Chemotherapy and immunotherapy in urologic oncologyedited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi.
其他題名:	a guide for the advanced practice provider /
其他作者:	Trabulsi, Edouard J.
出版者:	Cham :Springer International Publishing :2021.
面頁冊數:	xiv, 307 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Urinary organsCancer
電子資源:	https://doi.org/10.1007/978-3-030-52021-2
ISBN:	9783030520212$q(electronic bk.)

Chemotherapy and immunotherapy in urologic oncologya guide for the advanced practice provider /
Chemotherapy and immunotherapy in urologic oncologya guide for the advanced practice provider /[electronic resource] :edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi. - Cham :Springer International Publishing :2021. - xiv, 307 p. :ill., digital ;24 cm.

Introduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer.

This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book's chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects.

ISBN: 9783030520212$q(electronic bk.)

Standard No.: 10.1007/978-3-030-52021-2doiSubjects--Topical Terms:

725171
Urinary organs
--Cancer

LC Class. No.: RC280.U74

Dewey Class. No.: 616.9946

Chemotherapy and immunotherapy in urologic oncologya guide for the advanced practice provider /
LDR:03403nmm a2200325 a 4500 001 595241
003 DE-He213
005 20200929021821.0
006 m d
007 cr nn 008maaau
008 211005s2021 sz s 0 eng d
020 $a 9783030520212$q(electronic bk.)
020 $a 9783030520205$q(paper)
024 7 $a 10.1007/978-3-030-52021-2 $2 doi
035 $a 978-3-030-52021-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.U74
072 7 $a MJS $2 bicssc
072 7 $a MED088000 $2 bisacsh
072 7 $a MJS $2 thema
082 0 4 $a 616.9946 $2 23
090 $a RC280.U74 $b C517 2021
245 0 0 $a Chemotherapy and immunotherapy in urologic oncology $h [electronic resource] : $b a guide for the advanced practice provider / $c edited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a xiv, 307 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer.
520 $a This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book's chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects.
650 0 $a Urinary organs $x Cancer $x Treatment. $3 725171
650 1 4 $a Urology. $3 318461
650 2 4 $a Oncology. $3 195181
650 2 4 $a General Practice / Family Medicine. $3 274216
650 2 4 $a Primary Care Medicine. $3 275823
700 1 $a Trabulsi, Edouard J. $3 887359
700 1 $a Lallas, Costas D. $3 887360
700 1 $a Lizardi-Calvaresi, Anne E. $3 887361
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-52021-2
950 $a Medicine (SpringerNature-11650)